RELOFIN EVISTA OSTEOX RALOX REVERA OSTEONIL DENSER RALOXI HOXIF BIOVISTA BIOVISTA LOXIAM

Dose: 60 mg
Single Dose: 60 (60)
Frequency: 24 hourly
Route: PO
Instructions:

Dose: Not applicable in paeds
Single Dose:
Frequency:
Route:
Instructions:

belongs to Benzothiophene. It belongs to Oestrogen Agonist pharmacological group on the basis of mechanism of action and also classified in Hormones and Hormones pharmacological group.The Molecular Weight of Raloxifene (HCl) is 510.00.

Raloxifene (HCl) is contraindicated in conditions like Thrombosis,Vaginal bleeding.

The symptomatic adverse reactions produced by Raloxifene (HCl) are more or less tolerable and if they become severe, they can be treated symptomatically, these include Flatulence, Nausea, Vomiting, Fever, Insomnia, Rashes, Depression, Weight gain, Hot flushes, Increased intracranial pressure, Migraine, Gastroenteritis.

Raloxifene (HCl) is primarily indicated in conditions like Prevention of osteoporosis, Sedation with amnesia, and can also be given in adjunctive therapy as an alternative drug of choice in Postmenopausal disorders.

No data regarding the interactions of Raloxifene (HCl) was found.

Drug should not be given to Pregnant Mothers.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

Tab Store Between 20°C-25°C. Protect from Sunlight and Moisture.

Raloxifene should be used with caution in patients with any allergy (especially drug allergies), blood clots, heart failure, cancer or liver disease. This drug should be stopped at least 3 days before and during long periods of inactivity (e.g.bed rest). Blood clots, though unlikely, are more common when not moving. Avoid long periods of sitting or lying down during travel. This drug should not be used during pregnancy or lactation. This drug should not be used in children.